spot_img
spot_imgspot_img
May 16, 2026 - 8:23 AM

NAFDAC Orders Recall of Contaminated Amoxycillin Batch  

The National Agency for Food and Drug Administration and Control (NAFDAC) has begun a recall of a specific batch of Deekins Amoxycillin 500mg Capsules due to reports of severe adverse reactions. 
The affected batch, identified as lot number 4C639001, was manufactured by Eco-med Pharma Ltd and distributed by DevineKings Pharmaceutical Ltd.
The recall decision came after a hospital reported three cases of serious reactions in patients who used this batch of the antibiotic.
Amoxycillin, commonly prescribed for bacterial infections such as sinusitis, pneumonia, and tonsillitis, is generally considered safe when used appropriately.
However, the reported incidents prompted immediate action to prevent further risks.
NAFDAC has urged consumers and healthcare providers to stop using the affected batch and report any related incidents.
 The public is advised to contact the nearest NAFDAC office for further guidance.
Doris Israel Ijeoma
Doris Israel Ijeoma
Doris Israel Ijeoma is a graduate of the Nigerian Institute of Journalism, Lagos. She writes Tech, Political, Business and Entertainment Articles. dorisisrael5@gmail.com
0 0 votes
Article Rating
Subscribe
Notify of
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments

Share post:

Subscribe

Latest News

More like this
Related

Backlash Trails Tinubu’s $1.25bn Loan Bid as World Bank Restricts Instagram Comments 

The World Bank has reportedly restricted comments on its...

UPDATE: Boko Haram Attack Disrupts Exams in Borno, Pupils Missing as Troops Begin Rescue

Troops of the Joint Task Force (North East), Operation...

Another US Strike Hits Nigeria, ISIS Deputy Abu-Bilal al-Minuki Reportedly Killed

United States President, Donald Trump, has claimed that American...

South Africa: We are all victims

South Africa has pursued post-apartheid policies, the consequences of...
Join us on
For more updates, columns, opinions, etc.
WhatsApp
0
Would love your thoughts, please comment.x
()
x